Literature DB >> 33504108

Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients.

Malgorzata Mrugacz1, Anna Bryl1, Katarzyna Zorena2.   

Abstract

Diabetes mellitus (DM) has become a vital societal problem as epidemiological studies demonstrate the increasing incidence of type 1 and type 2 diabetes. Lesions observed in the retina in the course of diabetes, referred to as diabetic retinopathy (DR), are caused by vascular abnormalities and are ischemic in nature. Vascular lesions in diabetes pertain to small vessels (microangiopathy) and involve precapillary arterioles, capillaries and small veins. Pericyte loss, thickening of the basement membrane, and damage and proliferation of endothelial cells are observed. Endothelial cells (monolayer squamous epithelium) form the smooth internal vascular lining indispensable for normal blood flow. Breaking its continuity initiates blood coagulation at that site. The endothelium controls the process of exchange of chemical substances (nutritional, regulatory, waste products) between blood and the retina, and blood cell passing through the vascular wall. Endothelial cells produce biologically active substances involved in blood coagulation, regulating vascular wall tension and stimulating neoangiogenesis. On the other hand, recent studies have demonstrated that diabetic retinopathy may be not only a microvascular disease, but is a result of neuroretinal degeneration. Neuroretinal degeneration appears structurally, as neural apoptosis of amacrine and Muller cells, reactive gliosis, ganglion cell layer/inner plexiform (GCL) thickness, retinal thickness, and retinal nerve fiber layer thickness, and a reduction of the neuroretinal rim in minimum rim width (MRW) and functionally as an abnormal electroretinogram (ERG), dark adaptation, contrast sensitivity, color vision, and microperimetric test. The findings in early stages of diabetic retinopathy may precede microvascular changes of this disease. Furthermore, the article's objective is to characterize the factors and mechanisms conducive to microvascular changes and neuroretinal apoptosis in diabetic retinopathy. Only when all the measures preventing vascular dysfunction are determined will the risk of complications in the course of diabetes be minimized.

Entities:  

Keywords:  diabetes; diabetic retinopathy; dysfunction; endothelium; retinal neurodegeneration; retinal vessels

Year:  2021        PMID: 33504108      PMCID: PMC7866162          DOI: 10.3390/jcm10030458

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  127 in total

Review 1.  Endothelin system: the double-edged sword in health and disease.

Authors:  R M Kedzierski; M Yanagisawa
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 2.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 3.  Retinal microglia: just bystander or target for therapy?

Authors:  Marcus Karlstetter; Rebecca Scholz; Matt Rutar; Wai T Wong; Jan M Provis; Thomas Langmann
Journal:  Prog Retin Eye Res       Date:  2014-12-02       Impact factor: 21.198

4.  Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients.

Authors:  Katarina Cvitkovic; Antonio Sesar; Irena Sesar; Anita Pusic-Sesar; Renato Pejic; Tomislav Kelava; Alan Sucur; Ivan Cavar
Journal:  Semin Ophthalmol       Date:  2020-04-20       Impact factor: 1.975

5.  Circulating Leukocyte Alterations and the Development/Progression of Diabetic Retinopathy in Type 1 Diabetic Patients - A Pilot Study.

Authors:  Gideon Obasanmi; Noemi Lois; David Armstrong; Nuala-Jane Lavery; Jose Romero Hombrebueno; Aisling Lynch; David M Wright; Mei Chen; Heping Xu
Journal:  Curr Eye Res       Date:  2020-01-30       Impact factor: 2.424

6.  Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy.

Authors:  Shuang Song; Xiaobing Yu; Peng Zhang; Hong Dai
Journal:  J Diabetes Complications       Date:  2020-05-30       Impact factor: 2.852

7.  Contrast sensitivity in diabetics with and without background retinopathy.

Authors:  S Sokol; A Moskowitz; B Skarf; R Evans; M Molitch; B Senior
Journal:  Arch Ophthalmol       Date:  1985-01

8.  The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.

Authors:  Małgorzata Myśliwiec; Anna Balcerska; Katarzyna Zorena; Jolanta Myśliwska; Paweł Lipowski; Krystyna Raczyńska
Journal:  Diabetes Res Clin Pract       Date:  2007-08-22       Impact factor: 5.602

9.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 10.  Pathophysiology of Diabetic Retinopathy: The Old and the New.

Authors:  Sentaro Kusuhara; Yoko Fukushima; Shuntaro Ogura; Naomi Inoue; Akiyoshi Uemura
Journal:  Diabetes Metab J       Date:  2018-10       Impact factor: 5.376

View more
  21 in total

1.  Downregulation of glycoprotein non-metastatic melanoma protein B prevents high glucose-induced angiogenesis in diabetic retinopathy.

Authors:  Tingyu Qin; Xiangying Xi; Zhipeng Wu
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

Review 2.  Small Heat Shock Proteins in Retinal Diseases.

Authors:  Vivian Rajeswaren; Jeffrey O Wong; Dana Yabroudi; Rooban B Nahomi; Johanna Rankenberg; Mi-Hyun Nam; Ram H Nagaraj
Journal:  Front Mol Biosci       Date:  2022-04-11

3.  Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury.

Authors:  Steven F Abcouwer; Sumathi Shanmugam; Arivalagan Muthusamy; Cheng-Mao Lin; Dejuan Kong; Heather Hager; Xuwen Liu; David A Antonetti
Journal:  J Neuroinflammation       Date:  2021-08-26       Impact factor: 8.322

4.  Favourable Changes in C-Peptide, C-Reactive Protein and Lipid Profile, and Improved Quality of Life in Patients with Abnormal Body Mass Index after the Use of Manual Lymphatic Drainage: A Case Series with Three-Month Follow-Up.

Authors:  Klaudia Antoniak; Katarzyna Zorena; Rita Hansdorfer-Korzon; Dagmara Wojtowicz; Marek Koziński
Journal:  Medicina (Kaunas)       Date:  2022-02-11       Impact factor: 2.430

5.  Long non-coding ribonucleic acid ATP2B1-AS1 modulates endothelial permeability through regulating the miR-4729-IQGAP2 axis in diabetic retinopathy.

Authors:  Zengjin Ren; Xue Wang
Journal:  J Diabetes Investig       Date:  2022-01-25       Impact factor: 4.232

6.  High Glucose-Induced Apoptosis Is Linked to Mitochondrial Connexin 43 Level in RRECs: Implications for Diabetic Retinopathy.

Authors:  Aravind Sankaramoorthy; Sayon Roy
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

7.  Redox and Calcium Alterations of a Müller Cell Line Exposed to Diabetic Retinopathy-Like Environment.

Authors:  Clarissa Rosato; Barbara Bettegazzi; Pia Intagliata; Maria Balbontin Arenas; Daniele Zacchetti; Antonella Lanati; Gianpaolo Zerbini; Francesco Bandello; Fabio Grohovaz; Franca Codazzi
Journal:  Front Cell Neurosci       Date:  2022-03-18       Impact factor: 5.505

8.  Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Authors:  Salma El-Sayed Radwan; Amal El-Kamel; Eiman I Zaki; Susi Burgalassi; Erica Zucchetti; Riham M El-Moslemany
Journal:  Int J Nanomedicine       Date:  2021-07-02

9.  Impact of Injection Protocol Selection by Retina Specialists on Clinical Outcomes in Patients with Diabetic Macular Edema.

Authors:  Anika Tanwani; Nida Safdar; Amir Ali; Cina Karimaghaei; Mary Schmitz-Brown; Ahmad Rehmani; Praveena K Gupta
Journal:  Life (Basel)       Date:  2021-12-31

Review 10.  An Overview of Vascular Dysfunction and Determinants: The Case of Children of African Ancestry.

Authors:  Edna N Matjuda; Godwill Azeh Engwa; Constance R Sewani-Rusike; Benedicta N Nkeh-Chungag
Journal:  Front Pediatr       Date:  2021-12-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.